Literature DB >> 2167332

Serotype variation of human group A rotaviruses in two regions of the USA.

D O Matson1, M K Estes, J W Burns, H B Greenberg, K Taniguchi, S Urasawa.   

Abstract

The first longitudinal study of group A rotavirus serotype distribution in the USA is reported. ELISAs incorporating neutralizing monoclonal antibodies specific for the VP7 protein of serotypes 1, 2, 3, and 4 were used to determine the antigenic variation of group A rotaviruses in two collections of stool specimens. Stool samples were collected from children hospitalized during 1979-1989 at Texas Children's Hospital, Houston, and from children from a more rural population hospitalized during 1981-1989 in the north-central USA. The predominant serotype varied from year to year in Houston, with serotypes 1, 3, and 4 each predominant in 1 or more years. In the north-central population only serotype 1 was predominant each year. Within a single rotavirus season in the Houston area, serotypes were not equally distributed by week of the season or county of residence. These differences in the distribution of serotypes have broad implications for the design and interpretation of vaccine programs.

Entities:  

Mesh:

Year:  1990        PMID: 2167332     DOI: 10.1093/infdis/162.3.605

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

1.  Distribution of human rotavirus G types circulating in Paris, France, during the 1997-1998 epidemic: high prevalence of type G4.

Authors:  E Gault; R Chikhi-Brachet; S Delon; N Schnepf; L Albiges; E Grimprel; J P Girardet; P Begue; A Garbarg-Chenon
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Detection and characterization of novel rotavirus strains in the United States.

Authors:  V Gouvea; N Santos
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

3.  Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995.

Authors:  L E Unicomb; G Podder; J R Gentsch; P A Woods; K Z Hasan; A S Faruque; M J Albert; R I Glass
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

4.  Comparisons of rotavirus VP7-typing monoclonal antibodies by competition binding assay.

Authors:  P Raj; D O Matson; B S Coulson; R F Bishop; K Taniguchi; S Urasawa; H B Greenberg; M K Estes
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

5.  Serotype variation of group A rotaviruses over nine winter epidemics in southeastern New England.

Authors:  R E Begue; P H Dennehy; J Huang; P Martin
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

6.  Distribution of serotypes of human rotavirus in different populations.

Authors:  P A Woods; J Gentsch; V Gouvea; L Mata; M Santosham; Z S Bai; S Urasawa; R I Glass
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

7.  Detection and characterization of novel rotavirus strains in the United States.

Authors:  M Ramachandran; J R Gentsch; U D Parashar; S Jin; P A Woods; J L Holmes; C D Kirkwood; R F Bishop; H B Greenberg; S Urasawa; G Gerna; B S Coulson; K Taniguchi; J S Bresee; R I Glass
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

8.  Mutations in rotavirus nonstructural glycoprotein NSP4 are associated with altered virus virulence.

Authors:  M Zhang; C Q Zeng; Y Dong; J M Ball; L J Saif; A P Morris; M K Estes
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

9.  Surveillance of rotavirus strains in the United States: identification of unusual strains. The National Rotavirus Strain Surveillance System collaborating laboratories.

Authors:  D D Griffin; C D Kirkwood; U D Parashar; P A Woods; J S Bresee; R I Glass; J R Gentsch
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

10.  Group A rotavirus G type prevalence in two regions of Hungary.

Authors:  G Szücs; D O Matson; M Uj; E Kukán; I Mihály; Z Jelenik; M K Estes
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.